Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 452 | 298 | 1,100 | -759 | 387 |
| Gross Profit | 452 | 298 | 1,100 | -759 | 387 |
| Operating Expenses | 21,518 | 22,109 | 22,989 | 25,972 | 17,962 |
| Operating Income | -21,066 | -21,811 | -21,889 | -26,731 | -17,575 |
| Other Income | -14,836 | 37,697 | 4,179 | 16,765 | -6,608 |
| Pre-tax Income | -35,902 | 15,886 | -17,710 | -9,966 | -24,183 |
| Net Income Continuous | -35,902 | 15,886 | -17,710 | -10,253 | -24,183 |
| Net Income | $-35,902 | $15,886 | $-17,710 | $-10,253 | $-24,183 |
| EPS Basic Total Ops | -1.38 | 0.51 | -0.68 | 6.57 | -1.13 |
| EPS Basic Continuous Ops | -1.38 | 0.61 | -0.68 | 6.31 | -1.13 |
| EPS Diluted Total Ops | -1.38 | 0.50 | -0.68 | 6.60 | -1.13 |
| EPS Diluted Continuous Ops | -1.38 | 0.60 | -0.68 | 6.38 | -1.13 |
| EPS Diluted Before Non-Recurring Items | -1.38 | 0.50 | -0.68 | N/A | -0.69 |
| EBITDA(a) | $-20,460 | $-21,222 | $-20,733 | $-26,245 | $-17,289 |